title: High-flux dialysis lowers plasma leptin concentration in chronic dialysis patients.
abstract: Leptin is a protein produced by fat cells and involved in body weight regulation. Plasma leptin is significantly higher in some hemodialysis (HD) patients than in normal controls. We examined the influence of dialyzer membrane biocompatibility and flux on elevated plasma leptin concentrations in hemodialysis patients. Employing a crossover design, leptin and tumor necrosis factor-alpha (TNF-alpha) levels were serially determined in eight chronic dialysis patients. Patients were dialyzed sequentially on low-flux cellulosic (TAF) dialyzers, low-flux (F8) polysulfone, high-flux (F80B) polysulfone, then low-flux polysulfone and cellulosic dialyzers again. Mean leptin concentrations were similar when low-flux polysulfone or cellulosic dialyzers were employed (141.9+/-24.2 microg/L versus 137.8+/-18.4 microg/L, respectively (P=NS). In contrast, leptin fell significantly on the high-flux polysulfone dialyzer (99.4+/-16.2 microg/L) compared with cellulosic (P < 0.005), and low-flux polysulfone dialyzers (P < 0.02). Leptin clearance by the high-flux polysulfone dialyzer was significantly higher than the low-flux dialyzers (50.4+/-21.5 v -9.6+/-10.3 mL/min; P=0.043), but did not account fully for the 30% decline in plasma leptin during the high-flux arm of the study. Concentrations of TNF-alpha were lower when high-flux polysulfone dialyzers were employed, but there was no correlation of individual TNF-alpha levels with leptin concentrations. High-flux dialysis lowers plasma leptin concentrations an average of 30%, but biocompatibility does not influence leptin levels. The decrease in plasma leptin on high-flux dialysis cannot be explained solely by enhanced clearance.
authors.affiliation: Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110-1093, USA. dcoyne@imgate.wustl.edu
authors.forename: D W
authors.initials: DW
authors.lastname: Coyne
authors.forename: S
authors.initials: S
authors.lastname: Dagogo-Jack
authors.forename: S
authors.initials: S
authors.lastname: Klein
authors.forename: E
authors.initials: E
authors.lastname: Merabet
authors.forename: J
authors.initials: J
authors.lastname: Audrain
authors.forename: M
authors.initials: M
authors.lastname: Landt
mesh_terms: D018592:Cross-Over Studies; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy; D020738:Leptin; D008297:Male; D008875:Middle Aged; D011506:Proteins / Q000032:analysis*; D011863:Radioimmunoassay; D006435:Renal Dialysis / Q000295:instrumentation / Q000379:methods* / Q000706:statistics & numerical data; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
chemical_list: D020738:Leptin; D011506:Proteins; D014409:Tumor Necrosis Factor-alpha